Inventiva (IVA) Operating Leases (2022 - 2025)

Inventiva (IVA) posted quarterly Operating Leases of $3.3 million for Q4 2025, up 21.04% year-over-year from $2.7 million in Q4 2024, and down 28.5% quarter-over-quarter from $4.6 million in Q2 2025.

Inventiva (IVA) Operating Leases (2022 - 2025) Analysis & Trends

Inventiva's Operating Leases history runs 4 years deep, the most recent figure standing at $3.3 million for Q4 2025.

  • In Q4 2025, Operating Leases rose 21.04% year-over-year to $3.3 million; the TTM figure through Dec 2025 stood at $3.3 million (up 21.04% YoY), while the FY2025 annual figure was $3.3 million, up 21.04% from the prior year.
  • Operating Leases for Q4 2025 stood at $3.3 million, down from $4.6 million in the prior quarter.
  • The five-year high for Operating Leases was $7.1 million in Q2 2024, with the low at $2.7 million in Q4 2024.
  • The 4-year median for Operating Leases is $4.6 million (2023), against an average of $4.6 million.
  • Peak annual rise in Operating Leases reached 31.64% in 2024, while the deepest fall reached 41.35% in 2024.
  • Inventiva's Operating Leases stood at $4.6 million in 2022, then decreased by 0.22% to $4.6 million in 2023, then plunged by 41.35% to $2.7 million in 2024, then rose by 21.04% to $3.3 million in 2025.
  • Business Quant data shows IVA's Operating Leases at $3.3 million in Q4 2025, $4.6 million in Q2 2025, and $2.7 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Inventiva 888.89 Mn 888.89 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.26 Mn
Jun 30, 2025 4.56 Mn
Dec 31, 2024 2.69 Mn
Jun 30, 2024 7.07 Mn
Dec 31, 2023 4.59 Mn
Jun 30, 2023 5.37 Mn
Dec 31, 2022 4.60 Mn